WeFunder Secured and Launches Crowdfunding for Emerging AI Startup

BIRMINGHAM, Mich. - Oct. 21, 2020 - PRLog -- MARUX INC. is now offering common shares to the general public through an equity (Regulation-CF) crowdfunding platform in compliance with the Securities and Exchange Commission (SEC). The campaign is the first time MARUX™ is offering shares to the public at large, in parallel the company is also raising $25M through private sales of common shares to accredited investors. The offering is priced at a discounted rate per share to non-accredited investors. www.wefunder.com/marux

The application will be the industry first real-time diagnostic tool for emergency first responders and medical professionals. It is enhanced by machine learning (ML) together with artificial intelligence (AI), to help in all emergency assessments; fully secured by multiple U.S. patents and EU international patent applications.

With ambitious growth plans, MARUX™ is looking for shareholders to invest in its early stages of development and conditional beta testing through a scaled approach with first responder municipalities and hospital groups. The company use of initial crowdfunding rounds will be for furthering it's machine learning and artificial intelligence functionalities for various medical emergency use cases which includes basic vitals, physical injury assessments and facial visual recognition that extends its reach into Covid pandemic vitals.

The organization is led by a seasoned leadership team that that collectively has over 40+ years of medical, AI, ML, augmented reality (AR), software, first responders, automotive and transportation safety. The company medical and machine learning advisory board has educational training from leading universities and research institutions, including M.I.T., University of Michigan, Washington, Michigan State and Harvard.

About MARUX
MARUX, LLC is a software as a service (SaaS) dedicated to advancing the use of technology in the remote medical monitoring, medical diagnostics, and emergency medical services channels. The company is focused on developing extended/cross-reality (XR), augmented reality (AR), machine learning (ML), and artificial intelligence (AI), for remote diagnostics through telematics, and remote monitoring software application in medical healthcare. For more information, http://www.wefunder.com/MARUX